Dr. Catherine Cherwin's program of research includes symptom cluster, gastrointestinal (GI) microbiome, and non-pharmacologic management of symptoms in people with cancer. The focus of her work is to describe co-occurring symptoms in people with cancer, the potential biologic mechanisms for these symptoms including changes in the naturally occurring bacteria of the gut, and to eventually design and test non-pharmacologic interventions to lessen the severity of GI symptoms and improve quality of life in people with cancer. 

Dr. Cherwin’s work utilizes patient-reported measures of symptoms as well as biologic measures of the GI microbiome to describe the basis of GI symptom burden in people with cancer. Her current work is exploring how the GI microbiome changes as a response to cancer, chemotherapy, and obesity in women with breast cancer.

Curriculum Vitae